By 2018, the global cardiovascular information system market is expected to be valued at $232.9 million, growing at a compound annual growth rate of 7.8 percent, according to a Markets and Markets news release.
Supply Chain
In late March, the U.S. Food and Drug Administration released a report indicating medical device recalls had increased 97 percent over the last decade.
For providers wondering how much it would cost to improve capacity, Skanska USA's app, Prognos, has them covered.
Minneapolis-based Medtronic has acquired the majority of the shares of Biostar, a distribution company in Istanbul, Turkey.
HealthTrust Purchasing Group partnered with Hackensack (N.J.) University Medical Center to determine savings opportunities surrounding purchased services.
Charlotte, N.C.-based Premier has acquired College Station, Texas-based MEMdata, a technology management and capital equipment planning firm specializing in medical facilities.
The U.S. Food and Drug Administration has approved German pharmaceutical company Boehringer Ingelheim's Pradaxa (dabigatran etexilate) to treat deep venous thrombosis and pulmonary embolism for patients who have been treated with an injectable anticoagulant for five to 10 days, according…
A researcher has developed a new blood test that may be more effective in assessing risk of sudden cardiac death, according to a news release by the Cardiovascular Institute at Rhode Island Hospital, The Miriam Hospital and Newport Hospital.
3D Systems announced that it acquired Medical Modeling, a provider of personalized surgical treatments and patient-specific medical devices.
GS1, a global standards organization, has been accredited by the U.S. Food and Drug Administration as an issuing agency for unique device identifiers, according to a Supply & Demand Chain Executive report.